Torrent Pharmaceuticals Limited
TORNTPHARM
Rang in Aktien
#1197
Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity,... Torrent Pharmaceuticals Limited operates as a global pharmaceutical entity, managing the entire process from the discovery and development of generic drug formulations to their production and distribution. Its commercial activities extend across key markets such as India, the United States, Germany, and Brazil, alongside various other international territories. The company boasts a broad product catalog, offering treatments for a wide array of medical conditions. This includes therapies for cardiovascular diseases, central nervous system disorders, gastrointestinal issues, women's health concerns, diabetes, pain management, gynecological ailments, oncology, and anti-infective medications. Additionally, Torrent Pharma supplies essential vitamins, minerals, and other nutritional supplements. Beyond its proprietary offerings, the firm also provides contract manufacturing services to other companies. During the COVID-19 pandemic, it demonstrated its commitment by securing licensing agreements for crucial treatments like Baricitinib, Molnupiravir, and Paxlovid. Established in 1959, the company originally operated under the name Trinity Laboratories before officially becoming Torrent Pharmaceuticals Limited in 1971. Its corporate headquarters are located in Ahmedabad, India. Ultimately, Torrent Pharmaceuticals Limited functions as a subsidiary of Torrent Investments Private Limited.
Aktienkurs
$50.31
Zuletzt synchronisiert: 2026-10-19
Marktkapitalisierung
$19.14B
Veränderung (1 Tag)
-0.14%
Veränderung (1 Jahr)
23.83%
Land
IN
Handel Torrent Pharmaceuticals Limited (TORNTPHARM)
Kategorie
Healthcare
P/S-Verhältnis für Torrent Pharmaceuticals Limited (TORNTPHARM)
P/S-Verhältnis zum October 2026 TTM: 11.25
Laut den neuesten Finanzberichten und dem Aktienkurs von Torrent Pharmaceuticals Limited beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 11.25. Am Ende des Jahres 2024 lag das P/S-Verhältnis bei 8.44.
P/S-Verlauf für Torrent Pharmaceuticals Limited von 2005 bis 2026
P/S-Verhältnis zum Jahresende
| Jahr | P/S-Verhältnis | ändert |
|---|---|---|
| 2026 (TTM) | 11.25 | 20.14% |
| 2025 | 9.36 | 10.85% |
| 2024 | 8.44 | 56.08% |
| 2023 | 5.41 | -2.62% |
| 2022 | 5.55 | 3.21% |
| 2021 | 5.38 | 28.02% |
| 2020 | 4.20 | 0.30% |
| 2019 | 4.19 | 16.34% |
| 2018 | 3.60 | -20.28% |
| 2017 | 4.52 | 32.80% |
| 2016 | 3.40 | -19.26% |
| 2015 | 4.21 | 120.99% |
| 2014 | 1.91 | 6.16% |
| 2013 | 1.80 | -12.68% |
| 2012 | 2.06 | -11.14% |
| 2011 | 2.31 | -3.91% |
| 2010 | 2.41 | 246.41% |
| 2009 | 0.70 | -20.93% |
| 2008 | 0.88 | -31.07% |
| 2007 | 1.28 | -32.86% |
| 2006 | 1.90 | 11.12% |
| 2005 | 1.71 | 0.00% |
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
| Unternehmen | P/S-Verhältnis | P/S-Verhältnis-Differenz | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -37.24% |
IN
|
